590 related articles for article (PubMed ID: 27693788)
1. Enforced expression of hsa-miR-125a-3p in breast cancer cells potentiates docetaxel sensitivity via modulation of BRCA1 signaling.
Xu X; Lv YG; Yan CY; Yi J; Ling R
Biochem Biophys Res Commun; 2016 Oct; 479(4):893-900. PubMed ID: 27693788
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Docetaxel Sensitivity in Prostate Cancer Cells by hsa-miR-125a-3p via Modulation of Metastasis-Associated Protein 1 Signaling.
Liu JZ; Yin FY; Yan CY; Wang H; Luo XH
Urology; 2017 Jul; 105():208.e11-208.e17. PubMed ID: 28088556
[TBL] [Abstract][Full Text] [Related]
3. MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.
Zhang HD; Sun DW; Mao L; Zhang J; Jiang LH; Li J; Wu Y; Ji H; Chen W; Wang J; Ma R; Cao HX; Wu JZ; Tang JH
Biochem Biophys Res Commun; 2015 Oct; 465(4):702-13. PubMed ID: 26299922
[TBL] [Abstract][Full Text] [Related]
4. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
Kastl L; Brown I; Schofield AC
Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
[TBL] [Abstract][Full Text] [Related]
5. miR-125a-3p inhibits ERα transactivation and overrides tamoxifen resistance by targeting CDK3 in estrogen receptor-positive breast cancer.
Zheng L; Meng X; Li X; Zhang Y; Li C; Xiang C; Xing Y; Xia Y; Xi T
FASEB J; 2018 Feb; 32(2):588-600. PubMed ID: 28939591
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA hsa_circ_0052112 promotes cell migration and invasion by acting as sponge for miR-125a-5p in breast cancer.
Zhang HD; Jiang LH; Hou JC; Zhong SL; Zhou SY; Zhu LP; Li J; Wang DD; Sun DW; Ji ZL; Tang JH
Biomed Pharmacother; 2018 Nov; 107():1342-1353. PubMed ID: 30257349
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA hsa-miR-125a-3p activates p53 and induces apoptosis in lung cancer cells.
Jiang L; Chang J; Zhang Q; Sun L; Qiu X
Cancer Invest; 2013 Oct; 31(8):538-44. PubMed ID: 24044511
[TBL] [Abstract][Full Text] [Related]
8. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.
Jiang L; Huang Q; Zhang S; Zhang Q; Chang J; Qiu X; Wang E
BMC Cancer; 2010 Jun; 10():318. PubMed ID: 20569443
[TBL] [Abstract][Full Text] [Related]
9. MiRNA-125a-3p is a negative regulator of the RhoA-actomyosin pathway in A549 cells.
Huang B; Luo W; Sun L; Zhang Q; Jiang L; Chang J; Qiu X; Wang E
Int J Oncol; 2013 May; 42(5):1734-42. PubMed ID: 23525486
[TBL] [Abstract][Full Text] [Related]
10. Survivin-targeting miR-542-3p overcomes HER3 signaling-induced chemoresistance and enhances the antitumor activity of paclitaxel against HER2-overexpressing breast cancer.
Lyu H; Wang S; Huang J; Wang B; He Z; Liu B
Cancer Lett; 2018 Apr; 420():97-108. PubMed ID: 29409974
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines.
Uhr K; Prager-van der Smissen WJC; Heine AAJ; Ozturk B; van Jaarsveld MTM; Boersma AWM; Jager A; Wiemer EAC; Smid M; Foekens JA; Martens JWM
PLoS One; 2019; 14(5):e0216400. PubMed ID: 31063487
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of docetaxel sensitivity by miR-638 via regulation of STARD10 pathway in human breast cancer cells.
Zhao G; Li Y; Wang T
Biochem Biophys Res Commun; 2017 May; 487(2):255-261. PubMed ID: 28412359
[TBL] [Abstract][Full Text] [Related]
13. Posttranscriptional upregulation of HER3 by HER2 mRNA induces trastuzumab resistance in breast cancer.
Li X; Xu Y; Ding Y; Li C; Zhao H; Wang J; Meng S
Mol Cancer; 2018 Aug; 17(1):113. PubMed ID: 30068375
[TBL] [Abstract][Full Text] [Related]
14. MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition.
Zhang Y; Wang Y; Wei Y; Li M; Yu S; Ye M; Zhang H; Chen S; Liu W; Zhang J
Sci Rep; 2015 Oct; 5():15424. PubMed ID: 26487539
[TBL] [Abstract][Full Text] [Related]
15. LGR5 acts as a target of miR-340-5p in the suppression of cell progression and drug resistance in breast cancer via Wnt/β-catenin pathway.
Shi S; Chen X; Liu H; Yu K; Bao Y; Chai J; Gao H; Zou L
Gene; 2019 Jan; 683():47-53. PubMed ID: 30300682
[TBL] [Abstract][Full Text] [Related]
16. Complex Epigenetic Regulation of Chemotherapy Resistance and Biohlogy in Esophageal Squamous Cell Carcinoma via MicroRNAs.
Lindner K; Eichelmann AK; Matuszcak C; Hussey DJ; Haier J; Hummel R
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29414899
[TBL] [Abstract][Full Text] [Related]
17. The highly expressed 5'isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration.
Salem O; Erdem N; Jung J; Münstermann E; Wörner A; Wilhelm H; Wiemann S; Körner C
BMC Genomics; 2016 Aug; 17():566. PubMed ID: 27502506
[TBL] [Abstract][Full Text] [Related]
18. Curcumin exerts inhibitory effects on undifferentiated nasopharyngeal carcinoma by inhibiting the expression of miR-125a-5p.
Gao W; Chan JY; Wong TS
Clin Sci (Lond); 2014 Nov; 127(9):571-9. PubMed ID: 24896104
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of hsa_circ_0007534 suppresses breast cancer cell proliferation and invasion by targeting miR-593/MUC19 signal pathway.
Song L; Xiao Y
Biochem Biophys Res Commun; 2018 Sep; 503(4):2603-2610. PubMed ID: 30139516
[TBL] [Abstract][Full Text] [Related]
20. LukS-PV-Regulated MicroRNA-125a-3p Promotes THP-1 Macrophages Differentiation and Apoptosis by Down-Regulating NF1 and Bcl-2.
Sun XX; Zhang SS; Dai CY; Peng J; Pan Q; Xu LF; Ma XL
Cell Physiol Biochem; 2017; 44(3):1093-1105. PubMed ID: 29179212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]